Linear Darier's disease successfully treated with 0.1% tazarotene gel "short-contact" therapy

European Journal of Dermatology

Volumn 16, Issue 1, 2006, Pages 59-61

  Brazzelli, Valeria ^a   Prestinari, Francesca ^a   Barbagallo, Tania ^a   Vassallo, Camilla ^a   Agozzino, Marina ^a   Borroni, Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

0.1 tazarotene gel; Darier's disease

Indexed keywords

TAZAROTENE;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BURNING SENSATION; CASE REPORT; CONTACT DERMATITIS; DARIER DISEASE; EDEMA; ERYTHEMA; GENE MUTATION; HUMAN; KERATOSIS; MALE; PRURITUS; SKIN IRRITATION; STATISTICAL MODEL; XEROSIS;

ADMINISTRATION, TOPICAL; ADULT; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GELS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOLYTIC AGENTS; KERATOSIS FOLLICULARIS; MALE; NICOTINIC ACIDS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 32344448163     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Burge SM, Wilkinson JD. Darier-White disease: A review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27: 40-50.
2. Rand R, Baden HP. Commentary: Darier-White disease. Arch Dermatol 1983; 119: 81-3.
3. Itin PH, Buchner SA, Happle R. Segmental manifestation of Darier disease. Dermatology 2000; 200: 254-7.
4. O'Malley MP, Haake A, Goldsmith L, Berg D. Localized Darier disease. Arch Dermatol 1997; 133: 1134-8.
5. Kreibich K. Zum Wesen der psorospermosis Darier. Arch Dermatol Syphilol 1906; 80: 367; (Wien).
6. Plantin P, Le Noac'h E, Leroy JP, Gourcuff H. Maladie de Darier, localisée, récidivante et photo-induite suivant les lignes de Blaschko. Ann Dermatol Venereol 1994; 121: 393-5.
7. Wada T, Shirakata Y, Takahashi H, Muratami S, Iizuka H, Suzuki H, Hashimoto K. A Japanese case of segmental Darier's disease caused by mosaicism for the ATP2A2 mutation. Br J Dermatol 2003; 149: 185-8.
8. Bale SJ, Toro JR. Genetic basis of Darier-White disease: bad pumps cause bumps. J Cutan Med Surg 2000; 4: 103-6.
9. Sakuntabhai A, Dhitavat J, Burge S, Hovnanian A. Mosaicism for ATP2A2 mutations causes segmental Darier's disease. J Invest Dermatol 2000; 115: 1144-7.
10. Thomas I, Shockman J, Epstein D. Linear keratosis follicularis: A specific entity? Report of a case responding to combined topical retinoid and α-hydroxy acid therapy. J Am Acad Dermatol 1989; 20: 1122-3.
11. Moore JA, Schosser RH. Unilateral keratosis follicularis. Cutis 1985; 35: 459-61.
12. Happle R. Linear Darier's or Grover's disease? J Am Acad Dermatol 2003; 49(6): 1200-1.
13. Starink TM, Woerderman MJ. Unilateral systematized keratosis follicularis. A variant of Darier's disease or an epidermal naevus (achantolytic dyskeratotic epidermal naevus)? Br J Dermatol 1981; 105: 207-14.
14. Chandraratna RAS. Tazarotene -first of a new generation of receptor-selective retinoids. Br J Dermatol 1996; 135(Suppl): 18-25.
15. Bershad S, Singer GK, Parente JE. Successful treatment of acne vulgaris using a new method. Arch Dermatol 2002; 138: 481-9.
16. Hoffmann B, Stege H, Ruzicka T, Lehmann P. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol 1999; 141: 642-6.
17. Oster-Schmidt C. The treatment of Darier's disease with topical tazarotene. Br J Dermatol 1999; 141: 603-4; [letter].
18. Marks R. Clinical safety of tazarotene in the treatment of plaque psoriasis. J Am Acad Dermatol 1997; 37: 25-32.
19. Veraldi S, Schianchi R. Short-contact therapy with tazarotene in psoriasis vulgaris. Dermatology 2003; 206: 347-8.
20. Veraldi S, Caputo R, Pacifico A, Peris K, Soda R, Chimenti S. Short contact therapy with tazarotene in psoriasis vulgaris. J Eur Acad Dermatol Venereol 2004; 18(suppl 2): 358.
21. Burkhart CG, Burkhart CN. Tazarotene gel for Darier's disease. J Am Acad Dermatol 1998; 38: 1001-2.
22. Micali G, Nasca MR. Tazarotene gel in childhood Darier disease. Pediatr Dermatol 1999; 16: 243-4.